Ever since the identification in 2001 of nucleolar oligomerization and binding domain 2 (NOD2) gene mutations in patients with Crohn's disease [3], [4], it is considered that the genetic factor in IBD relates to defective innate immunity. The gene discussed is NOD2; the disease is inflammatory bowel disease.